Press releases

Urolon™, bioresorbable urethral implant, is available through a network of distributors. For more information about the availability of Urolon™ in your region or distribution opportunities we invite you to contact us:

June 2023

On 20 March 2023, the Regulation (EU) 2023/607 amending the MDR 2017/745 and IVDR 2017/746 was published. The amendment allows previously issued MDD and AIMDD certificates which are expired, to be recognized as valid under certain specified conditions.

It is with great pleasure that we can announce that Urolon complies with all requirements needed to be granted CE-certificate validity extension until 31-Dec-2027. This means that the current CE certificate will remain valid until 31-Dec-2027.

June 2018

AQLANE Medical™ is proud to announce that Urolon™, its bioresorbable urethral bulking agent, has received CE certification. Click here to read the Press Release.